Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06927700 · ClinicalTrials.gov registry record · NA
Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes
A NA study, sponsored by Rutgers, The State University of New Jersey.
- Completed
- Registry status
- NA
- Development phase
- 1,257
- Enrollment target
NCT06927700 is a NA study that has completed, run by Rutgers, The State University of New Jersey. The registered enrollment target is 1,257 participants.
The verdict
NCT06927700, a NA study, has completed, sponsored by Rutgers, The State University of New Jersey.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,257 participants
- Enrollment target
Study Summary
This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the lower risks of these products compared to cigarette smoking. The study will compare effects of ads with different two different claim types (i.e. claims about reduced lung cancer risk and claims about reduced risks for multiple disease) versus ads with no reduced-risk claims, and examine effects on message and product perceptions, and interest in using the smokeless tobacco products. This study will also examine how smokers' reactions/interest may vary based on the product brand, and asses prior awareness/exposure to the authorized claims.
Interventions
- BEHAVIORAL Modified Risk Claim Type - None
- BEHAVIORAL Product Brand - General Snus
- BEHAVIORAL Product Brand - Copenhagen
- BEHAVIORAL Modified Risk Claim Type - Multiple Diseases
- BEHAVIORAL Modified Risk Claim Type - Lung Cancer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,257 participants |
| Start Date | 2025-04-24 |
| Est. Completion | 2025-05-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06927700
The ClinicalTrials.gov registry entry for NCT06927700 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Modified Risk Claim Type - None is the first listed.
NCT06927700 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06927700 about?
NCT06927700 is a clinical study titled "Effects of FDA Authorized Smokeless Tobacco Claims Among US Adults Who Smoke Cigarettes". This study will be an online survey experiment conducted with adults who smoke cigarettes (ages 21+) to examine their reactions to modified risk advertising claims authorized by the Food \& Drug Administration (FDA) for two smokeless tobacco brands (General Snus and Copenhagen), which describe the l...
What is the current status of trial NCT06927700?
This trial is currently completed. It is a NA study. The enrollment target is 1,257 participants. The study started on 2025-04-24. Estimated completion is 2025-05-04.
What interventions are being tested in trial NCT06927700?
The interventions under investigation include: Modified Risk Claim Type - None (BEHAVIORAL), Product Brand - General Snus (BEHAVIORAL), Product Brand - Copenhagen (BEHAVIORAL), Modified Risk Claim Type - Multiple Diseases (BEHAVIORAL), Modified Risk Claim Type - Lung Cancer (BEHAVIORAL).
Who is sponsoring clinical trial NCT06927700?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.